CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- RW Other RW
Page 19 of 20 · 384 filings